Catherine Dhanjal Q&A with ProQuest and Pi2 - Literature Monitoring in Drug Safety
Jinfo Article

20th October 2015

By Catherine Dhanjal

Abstract

We interviewed ProQuest and Pi2 management to find out more about the value of Pi2 to ProQuest's corporate pharmaceutical customers, how it helps drug safety departments to cope with increasing workloads and what makes for most effective literature monitoring in drug safety.

Content Access
Does your organisation have a Jinfo Subscription?

Access to Jinfo Content and Community is available through a Jinfo Subscription.

"Yes"

Please sign in to MyJinfo here so that we can check your access to this item:

Email:

Password:

  Forgotten password?


Or sign in via email:

Enter your email and we'll send you a magic link to sign you in automatically.

"Not yet"

Access to this article is available through a Jinfo Subscription, which will help your organisation:

  1. Save time and money
  2. Re-invent information services
  3. Define, measure and communicate information value.

Subscription Benefits


"Don't know"

Contact us to find out if your organisation already has a Jinfo Subscription.

Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.



 « All Articles